Literature DB >> 3259290

Development of CD4-CD8+ cytotoxic T cells requires interactions with class I MHC determinants.

S Maruŝić-Galesić1, D A Stephany, D L Longo, A M Kruisbeek.   

Abstract

Differentiation of bone marrow derived precursors into mature T cells takes place in the thymus. During differentiation, T cells develop the receptor repertoire which allows them to recognize antigen in the context of self major histocompatibility complex (MHC) molecules. Mature T helper cells (mostly CD4+ CD8-) recognize antigen in the context of class II MHC molecules, whereas cytotoxic T cells (mostly CD4-CD8+) recognize antigen in the context of class I MHC determinants. Thymic MHC-encoded determinants greatly influence the selection of the T-cell receptor repertoire. In addition to positive selection, a negative selection to eliminate self-reactive T-cell clones is thought to occur in the thymus, but how this 'education' occurs is not well understood. It has been suggested that during differentiation an interaction between the T-cell receptor (TCR) and MHC-encoded determinants occurs, leading to the selection of an MHC-restricted receptor repertoire. In support of this hypothesis, class-II-specific, CD4+ CD8- helper T cells fail to develop in mice neonatally treated with anti-class II monoclonal antibody (mAb). As CD4-CD8+ cells differ from the CD4+ CD8- lineage (in function, MHC-restriction specificity and perhaps site of education) we examined whether interactions with MHC determinants are also necessary for the development of class-I-specific T cells. Here we show that mice chronically treated with anti-class I mAb from birth lack CD4-CD8+ cells and cytotoxic T-cell precursors, indicating that most CD4-CD8+ T cells need interaction with class I MHC molecules during differentiation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3259290     DOI: 10.1038/333180a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  16 in total

1.  Unresponsiveness to Mlsa induced in newborn Mlsb mice by maternal preimmunization.

Authors:  A Matossian-Rogers; L DeGiorgi; L DeGiori
Journal:  Immunology       Date:  1991-02       Impact factor: 7.397

2.  Inheritance of T helper immunodeficiency (thid) in LEC mutant rats.

Authors:  T Yamada; T Natori; K Izumi; T Sakai; T Agui; K Matsumoto
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

Review 3.  Thymic selection of the T-cell repertoire.

Authors:  A M Kruisbeek; J Zúñiga-Pflücker; S Marusić-Galesić; M A Weston; L Tentori; D L Longo
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

4.  Increased number of CD4-CD8+ MHC class II-specific T cells in MHC class II-deficient mice.

Authors:  S Marusić-Galesić; P Walden
Journal:  Immunology       Date:  1995-07       Impact factor: 7.397

5.  Intrathymic maturation of murine T lymphocytes from CD8+ precursors.

Authors:  C J Guidos; I L Weissman; B Adkins
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

6.  Tolerance induction and endogenous regeneration of pancreatic beta-cells in established autoimmune diabetes.

Authors:  Charles Sia; Francoise Homo-Delarche
Journal:  Rev Diabet Stud       Date:  2005-02-10

7.  Prolactin increases CD4/CD8 cell ratio in thymus-grafted congenitally athymic nude mice.

Authors:  G O Gaufo; M C Diamond
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

Review 8.  Immune checkpoint inhibitor-associated myocarditis: manifestations and mechanisms.

Authors:  Javid Moslehi; Andrew H Lichtman; Arlene H Sharpe; Lorenzo Galluzzi; Richard N Kitsis
Journal:  J Clin Invest       Date:  2021-03-01       Impact factor: 14.808

9.  CD8 is required during positive selection of CD4-/CD8+ T cells.

Authors:  J C Zúñiga-Pflücker; L A Jones; D L Longo; A M Kruisbeek
Journal:  J Exp Med       Date:  1990-02-01       Impact factor: 14.307

10.  Skin graft rejection by beta 2-microglobulin-deficient mice.

Authors:  M Zijlstra; H Auchincloss; J M Loring; C M Chase; P S Russell; R Jaenisch
Journal:  J Exp Med       Date:  1992-04-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.